These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22715481)

  • 21. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
    Shoemaker RC; House DE
    Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
    Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 10 Hz repetitive transcranial magnetic stimulation (rTMS) on clinical global impression in chronic schizophrenia.
    Cordes J; Thünker J; Agelink MW; Arends M; Mobascher A; Wobrock T; Schneider-Axmann T; Brinkmeyer J; Mittrach M; Regenbrecht G; Wölwer W; Winterer G; Gaebel W
    Psychiatry Res; 2010 May; 177(1-2):32-6. PubMed ID: 20378181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
    Kinon BJ; Ascher-Svanum H; Adams DH; Chen L
    J Clin Psychopharmacol; 2008 Oct; 28(5):544-9. PubMed ID: 18794651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports.
    Pazooki K; Leibetseder M; Renner W; Gougleris G; Kapsali E
    Appl Psychophysiol Biofeedback; 2019 Mar; 44(1):31-39. PubMed ID: 30267339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steps toward developing an EEG biofeedback treatment for chronic pain.
    Jensen MP; Gertz KJ; Kupper AE; Braden AL; Howe JD; Hakimian S; Sherlin LH
    Appl Psychophysiol Biofeedback; 2013 Jun; 38(2):101-8. PubMed ID: 23532434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Exploratory Study of Intensive Neurofeedback Training for Schizophrenia.
    Nan W; Wan F; Chang L; Pun SH; Vai MI; Rosa A
    Behav Neurol; 2017; 2017():6914216. PubMed ID: 28701821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoencephalography self-regulation training and its impact on cognition: A study with schizophrenia and healthy participants.
    Gomes JS; Ducos DV; Gadelha A; Ortiz BB; Van Deusen AM; Akiba HT; Guimaraes LSP; Cordeiro Q; Trevizol AP; Lacerda A; Dias AM
    Schizophr Res; 2018 May; 195():591-593. PubMed ID: 28882685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EEG-neurofeedback and psychodynamic psychotherapy in a case of adolescent anhedonia with substance misuse: mood/theta relations.
    Unterrainer HF; Chen MJ; Gruzelier JH
    Int J Psychophysiol; 2014 Jul; 93(1):84-95. PubMed ID: 23535499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effectiveness of Visual Short-Time Neurofeedback on Brain Activity and Clinical Characteristics in Alcohol Use Disorders: Practical Issues and Results.
    Lackner N; Unterrainer HF; Skliris D; Wood G; Wallner-Liebmann SJ; Neuper C; Gruzelier JH
    Clin EEG Neurosci; 2016 Jul; 47(3):188-95. PubMed ID: 26415612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of a single session of upper alpha neurofeedback for cognitive enhancement: a sham-controlled study.
    Escolano C; Navarro-Gil M; Garcia-Campayo J; Minguez J
    Appl Psychophysiol Biofeedback; 2014 Dec; 39(3-4):227-36. PubMed ID: 25267413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of neurofeedback training as a treatment for opioid-dependent patients.
    Arani FD; Rostami R; Nostratabadi M
    Clin EEG Neurosci; 2010 Jul; 41(3):170-7. PubMed ID: 20722354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Dementia: 20 Cases. How Neurometric Analysis Is Important for the Treatment of Dementia and as a Biomarker?
    Surmeli T; Eralp E; Mustafazade I; Kos H; Özer GE; Surmeli OH
    Clin EEG Neurosci; 2016 Apr; 47(2):118-33. PubMed ID: 26099949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.